Clinical Trials
3 trialsNCT02619864 2023-08-04
mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Canadian Cancer Trials Group
Phase 1 Completed
NCT03071874 2022-10-18
Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
Massachusetts General Hospital
Phase 2 Unknown
NCT02831257 2022-06-13
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Massachusetts General Hospital
Phase 2 Completed